Abcuro reports preclincal data showing that KLRG1 antibody blockade produced anticancer responses in breast cancer, colon cancer, and melanoma models, supporting KLRG1 as a promising new immuno-oncology target.

Labshares announces new hires and leadership promotions to support its growing shared lab community and strengthen operations and member services across Greater Boston.

Labshares Newton, a shared office and laboratory space for emerging biotechnology and life science companies, announced that it has selected three startup companies developing COVID-19 diagnostics to receive free lab space.